Recently, investigations of inflammatory macrophages in chronic liver disease pointed out that TGR5 expression was reduced in liver samples from humans and mice suffering from NASH (Shi et al., 2020). This evidence concerns the gene GPBAR1 and metabolic dysfunction-associated steatohepatitis.